Extended Lymphadenectomy fails to Improve Survival in Muscle-Invasive Bladder Cancer Patients: NEJM Jacinthlyn Sylvia6 Oct 2024 10:45 PM ISTA recent study published in the New England Journal of Medicine and found no significant survival benefit of extended lymphadenectomy over standard...
Medical Bulletin 23/ September/ 2024 Dr. Bhumika Maikhuri23 Sept 2024 3:00 PM ISTHere are the top medical news for the day:Can Coffee Consumption Negate Harmful Effects of Sitting Too Much? BMC Study unveils associationA recent...
Combination Immunotherapy Shows Increased Survival and Antitumor Activity in Bladder Cancer Cases: Study Dr. Bhumika Maikhuri23 Sept 2024 8:00 AM ISTFindings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and tolerable in patients...
Immunotherapy after surgery may improve survival in people with high-risk bladder cancer: NEJM Dr. Kamal Kant Kohli18 Sept 2024 2:30 AM ISTResults from a large clinical trial show that treatment with an immunotherapy drug may nearly double the length of time people with high-risk,...
European Commission approves Janssen-Cilag Balversa for adult patients with metastatic urothelial carcinoma Ruchika Sharma25 Aug 2024 10:00 AM ISTBelgium: Janssen-Cilag International NV, a Johnson & Johnson company, has announced that the European Commission (EC) has approved...
FDA approves immunotherapy drug combo for non-muscle invasive bladder cancer Dr. Kamal Kant Kohli30 April 2024 7:00 AM ISTThe U.S. Food and Drug Administration (FDA) has approved the immunotherapy-boosting drug N-803, which is marketed under the brand name Anktiva, to be...
Urine test halves painful procedures in bladder cancer follow up, new trial shows Dr. Kamal Kant Kohli12 April 2024 6:00 AM ISTA simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. ...
Blood test can predict risk of relapse in advanced bladder cancer patients following surgery, suggests study Dr. Kamal Kant Kohli6 April 2024 7:00 AM ISTTesting for tumour DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following surgery, new research...
USFDA approves Opdivo in combo with Cisplatin and Gemcitabine for first-line treatment of adult patients with metastatic Urothelial Carcinoma: Bristol Myers Squibb Ruchika Sharma9 March 2024 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab), in combination...
New test could predict immunotherapy responders for broader range of cancers than current tools Dr. Kamal Kant Kohli15 Feb 2024 2:00 AM ISTA newly identified genetic marker could potentially predict which patients are likely to respond to immunotherapy in cancer types that have lacked...
JnJ Balversa gets full USFDA nod to treat locally advanced or metastatic Bladder Cancer with Select Genetic Alterations Ruchika Sharma21 Jan 2024 4:30 PM ISTRaritan: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application...
Medical Bulletin 17/January/2024 Anshika Mishra17 Jan 2024 3:00 PM ISTHere are the top medical news stories of the day:Bladder tumors reduced by 90% using nanorobotsBladder cancer has one of the highest incidence rates...
